Ensuring Superior Surgical Outcomes Through Technological Innovation As a dedicated physician, providing innovative treatment to your patients with ocular surface damage is a foremost priority. With this in mind, Bio-Tissue brings you a new generation of ocular surface tissue therapies designed to accelerate the regeneration of damaged tissue while reducing recipient discomfort associated with ocular surface reconstruction. Created using our patented cryopreservation method, AMNIOGRAFT® and PROKERA® provide the natural healing properties of amniotic membrane to restore ocular surface function with minimal inflammation and scarring. Our amniotic membrane allografts facilitate the short-term success of surgical procedures as well as the long-term stability of the eye surface when used as indicated. Bio-Tissue: Advancing the Science of Ocular Surface Reconstruction with Amniotic Membrane.
Amniotic membrane is the innermost lining of the placenta. It contains natural growth factors and cytokines which are integral to the healthy development of the fetus. When implanted on the ocular surface, amniotic membrane promotes faster wound repair and wound healing. By eliminating the need to harvest your patient’s own tissue, amniotic membrane reduces pain and discomfort, limits complications, reduces surgical time and optimizes surgical outcomes. Bio-Tissue has contributed over ten years of research and innovation to the ophthalmic community and remains committed to creating ophthalmic products that will advance and further simplify the treatment of ocular surface diseases. What Makes Our Amniotic Membrane Different?
Bio-Tissue offers the only commercially available amniotic membrane that preserves the native integrity, activity, and function exhibited by the tissue in utero for ocular surface wound repair and wound healing. Our proprietary processing and preservation method retains vital cytokines and growth factors which facilitate healing mechanisms such as: • Anti-inflammatory
• Anti-scarring
• Anti-angiogenic
• Pain reduction
• Promotion of epithelial healing Our products work synergistically with your patient’s own system to enhance and speed tissue repair, resulting in a calm, white eye with minimal discomfort—even immediately following surgery. Although the ophthalmic community has been aware of the healing implications of amniotic membrane allografts since the 1940s, the clinical and biological efficacy of amniotic membrane was not widely accepted until Bio-Tissue introduced its unprecedented technology in 1997. Since then, ophthalmologists worldwide have used AMNIOGRAFT® and PROKERA® to treat a wide array of ocular surface diseases and have enthusiastically endorsed their capabilities in ocular surface wound healing and repair. |